These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 11708594)
21. Cutaneous anthrax: an overview. Celia F Dermatol Nurs; 2002 Apr; 14(2):89-92. PubMed ID: 12017087 [TBL] [Abstract][Full Text] [Related]
22. From the Centers for Disease Control and Prevention. Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001. JAMA; 2001 Dec; 286(23):2935-6. PubMed ID: 11787481 [No Abstract] [Full Text] [Related]
23. Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(45):1024-6. PubMed ID: 12458919 [TBL] [Abstract][Full Text] [Related]
24. Inadvertent laboratory exposure to Bacillus anthracis--California, 2004. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2005 Apr; 54(12):301-4. PubMed ID: 15800474 [TBL] [Abstract][Full Text] [Related]
25. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(41):889-93. PubMed ID: 11686472 [TBL] [Abstract][Full Text] [Related]
26. Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfare. Jones ME; Goguen J; Critchley IA; Draghi DC; Karlowsky JA; Sahm DF; Porschen R; Patra G; DelVecchio VG Clin Microbiol Infect; 2003 Sep; 9(9):984-6. PubMed ID: 14616693 [TBL] [Abstract][Full Text] [Related]
27. [Anthrax in the era of biowarfare]. Bossi P; Bricaire F Presse Med; 2003 Feb; 32(4):167-73. PubMed ID: 12610473 [TBL] [Abstract][Full Text] [Related]
32. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001. Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664 [TBL] [Abstract][Full Text] [Related]
33. From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis. JAMA; 2001 Nov; 286(20):2536-7. PubMed ID: 11763846 [No Abstract] [Full Text] [Related]
34. Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947-2019. Kennedy JL; Bulitta JB; Chatham-Stephens K; Person MK; Cook R; Mongkolrattanothai T; Shin E; Yu P; Negron ME; Bower WA; Hendricks K Clin Infect Dis; 2022 Oct; 75(Suppl 3):S379-S391. PubMed ID: 36251546 [TBL] [Abstract][Full Text] [Related]
35. Antibiotics for anthrax: patient requests and physician prescribing practices during the 2001 New York City attacks. Hupert N; Chege W; Bearman GM; Pelzman FN Arch Intern Med; 2004 Oct; 164(18):2012-6. PubMed ID: 15477436 [TBL] [Abstract][Full Text] [Related]
38. Recognition and management of anthrax--an update. Swartz MN N Engl J Med; 2001 Nov; 345(22):1621-6. PubMed ID: 11704686 [No Abstract] [Full Text] [Related]
39. From the Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. JAMA; 2001 Nov; 286(18):2226-32. PubMed ID: 11757528 [No Abstract] [Full Text] [Related]
40. Occupational health guidelines for remediation workers at Bacillus anthracis-contaminated sites--United States, 2001-2002. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2002 Sep; 51(35):786-9. PubMed ID: 12227440 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]